Your browser doesn't support javascript.
loading
Avelumab and cetuximab as a therapeutic combination: An overview of scientific rationale and current clinical trials in cancer.
Bourhis, Jean; Stein, Alexander; Paul de Boer, Jan; Van Den Eynde, Marc; Gold, Kathryn A; Stintzing, Sebastian; Becker, Jürgen C; Moran, Michael; Schroeder, Andreas; Pennock, Gregory; Salmio, Satu; Esser, Regina; Ciardiello, Fortunato.
Afiliação
  • Bourhis J; Centre Hospitalier Universitaire Vaudois, Service de Radio-oncologie, Lausanne, Switzerland. Electronic address: Jean.Bourhis@chuv.ch.
  • Stein A; Hematology-Oncology Practice Hamburg (HOPE), University Cancer Center Hamburg, Hamburg, Germany.
  • Paul de Boer J; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Van Den Eynde M; Cliniques universitaires Saint-Luc, Institut Roi Albert II, Université Catholique de Louvain, Brussels, Belgium.
  • Gold KA; Department of Medicine, Division of Hematology-Oncology, University of California, San Diego, La Jolla, CA, USA.
  • Stintzing S; Department of Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Becker JC; Department of Translational Skin Cancer Research, German Cancer Consortium (DKTK), Essen University Hospital, Essen, Germany, and German Cancer Research Institute (DKFZ), Heidelberg, Germany.
  • Moran M; Pfizer Pharma GmbH, Berlin, Germany.
  • Schroeder A; Merck KGaA, Darmstadt, Germany.
  • Pennock G; EMD Serono Research & Development Institute, Inc., Billerica, MA, USA(2).
  • Salmio S; Merck KGaA, Darmstadt, Germany.
  • Esser R; Merck KGaA, Darmstadt, Germany.
  • Ciardiello F; Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy.
Cancer Treat Rev ; 97: 102172, 2021 Jun.
Article em En | MEDLINE | ID: mdl-33989949
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Treat Rev Ano de publicação: 2021 Tipo de documento: Article País de publicação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Treat Rev Ano de publicação: 2021 Tipo de documento: Article País de publicação: Holanda